洪达HD品牌怎么样 申请店铺

我要投票 洪达HD在医疗器械行业中的票数:106 更新时间:2025-02-23
洪达HD是哪个国家的品牌?「洪达HD」是 江西洪达医疗器械集团有限公司 旗下著名品牌。该品牌发源于江西省南昌市,由创始人王辉在1999-07-01期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力洪达HD品牌出海!通过在本页面挂载洪达HD品牌的产品链接和联系邮箱,可以提高洪达HD产品曝光!跨境电商爆单神器,目前只要100元/年哦~

洪达HD怎么样

江西洪达医疗器械集团有限公司,一次性行业耗材/无菌医疗器械制造商,致力于医疗器械的开发/生产/销售的现代化企业


江西洪达医疗器械集团有限公司是取得国家食品药品监督管理局一次性使用无菌医疗器具系列产品注册证认可的企业。位于风景秀丽的庐山、井岗山、龙虎山、三清山的中心地带,紧靠鄱阳湖,距省城南昌 60 公里 ,紧靠京九铁路、浙赣铁路、沪梨温高速、京福高速和 320 国道等交通大动脉穿城而过、交通十分便利。

集团公司现拥有注册资金 4.2888 亿元,流动资金 3.2 亿元。厂房占地面积600亩,符合 GMP 要求的 10 万级净化车间达 42000 平方米,员工总数达 5000 多人,汇集行业精英,与世界医疗产业互动。今天,洪达己成为美洲、欧洲、非洲、中东、东南亚无菌医疗器械市场的主要供货商。是中国一次性行业耗材生产、加工制造商之一,仅在中国就有近 1/4 的市场配额。

集团公司生产的“洪达”牌产品有九大类几十个品种:输液、输血器具类、注射器具类、穿刺器械类、检查或辅助器械类、麻醉器械类、导管类、医疗设备类、心血管介入类、血液净化制品类等。

集团公司始创于1987年,公司拥有20年的生产制造经验、高素质的管理队伍、先进的生产设备。其中高级职称人员 29 名,中级职称人员 48 名,专业技术人员 198 名,经国家和省级培训合格的专职检验员 26 名。公司实行了人性化管理,通过制订的各种规章、制度,充分调动和发挥员工的主动性和积极性,并提供各种机会对员工进行岗位培训,使员工能够不断的适应新的需求和接受新的挑战,实行公平,公正、客观的绩效考评制度,在人力资源方面,己形成了一套完善而具有凝聚力的管理体系。现公司有注塑机 168 台,挤出成型机 57 台, 20 立方米自动化程控灭菌柜53 台,注射针自动装配机 12 台,注射器自动装配机 36 台,自动包装机 5 台,自动滴斗成型机 16 台,自动断管机 45 台,输液针半自动组装生产线 5 条,高频热合机 60 台,吹塑制袋设备 80 台,组合式纯水设备 3 套,中央空调及冷水机组 23 套。注射器、注射针已基本完成自动化生产线,输液器、输液针已完成了流水组装生产线。

集团公司按照ISO 9001 、 ISO 13485标准建立了一套完善的质保体系,通过了按 ISO 9001 质量认证和欧盟的 CE 认证。产品在过程控制方面,推行“三检制”,运用三级质量管理网络;对产品从原材料进厂到产品的出厂,实行层层把关; 宁可严查百万,决不漏放一个。洪达人始终以“为客户提供安全、优质的产品”为己任,追求产品的零缺陷。

洪达人坚信没有今天的产品质量,就没有明天的销售市场,没有今天的顾客满意,就没有明天洪达的生命。 洪达产品始终以合理的性能价格面对市场,洪达人希望与广大客户共创洪达品牌。


Jiangxi Hongda Medical Equipment Group Co., Ltd., a manufacturer of disposable industrial consumables / sterile medical equipment, is a modern enterprise committed to the development, production and sales of medical equipment. Jiangxi Hongda Medical Equipment Group Co., Ltd. is an enterprise recognized by the national food and Drug Administration for the registration certificate of disposable sterile medical equipment series products. It is located in the center of Lushan Mountain, Jinggang Mountain, Longhu Mountain and Sanqing mountain with beautiful scenery, close to Poyang Lake, 60 kilometers away from Nanchang, the provincial city, close to Beijing Jiulong Railway, Zhejiang Jiangxi railway, Shanghai Lishui Wenzhou expressway, Beijing Fuzhou Expressway and 320 National Highway and other major traffic arteries passing through the city, with convenient traffic. The group now has a registered capital of 4288.8 million yuan and a working capital of 320 million yuan. The plant covers an area of 600 mu, with a 100000 level purification workshop meeting GMP requirements of 42000 square meters and a total of more than 5000 employees. It gathers industry elites and interacts with the world's medical industry. Today, Hongda has become the main supplier of sterile medical devices in America, Europe, Africa, the Middle East and Southeast Asia. It is one of the manufacturers of disposable industry consumables production and processing in China, with nearly 1 / 4 market quota in China alone. The "Hongda" brand products produced by the group company have nine categories and dozens of varieties: infusion, blood transfusion equipment, syringe equipment, puncture equipment, inspection or auxiliary equipment, anesthesia equipment, catheter, medical equipment, cardiovascular intervention, blood purification products, etc. Founded in 1987, the company has 20 years of production and manufacturing experience, high-quality management team, advanced production equipment. Among them, there are 29 senior title personnel, 48 intermediate title personnel, 198 professional and technical personnel, and 26 full-time inspectors who have passed the national and provincial training. The company has implemented humanized management, fully mobilized and exerted the initiative and enthusiasm of employees through various rules and regulations formulated, and provided various opportunities for on-the-job training of employees, so that employees can continuously adapt to new needs and accept new challenges, and implemented a fair, fair and objective performance evaluation system. In terms of human resources, it has formed a set of perfect A cohesive management system. At present, the company has 168 injection molding machines, 57 extrusion molding machines, 53 20 cubic meter automatic program-controlled sterilization cabinets, 12 injection needle automatic assembly machines, 36 syringe automatic assembly machines, 5 automatic packaging machines, 16 automatic drip bucket molding machines, 45 automatic pipe breaking machines, 5 semi-automatic assembly production lines for infusion needles, 60 high-frequency heat sealing machines, 80 blow molding and bag making equipment, 3 sets of combined pure water equipment 23 sets of central air conditioning and water chillers. The automatic production line has been basically completed for syringes and injection needles, and the assembly line for infusion sets and injection needles has been completed. The group company has established a set of perfect quality assurance system according to ISO9001 and ISO13485 standards, and passed ISO9001 quality certification and CE certification of EU. In the process control of products, the "three inspection system" shall be implemented, and the three-level quality management network shall be used; the products shall be checked at all levels from the arrival of raw materials to the delivery of products; it is better to check millions of products, and never miss one. Hongda people always take "providing safe and high quality products for customers" as their duty, and pursue zero defect of products. Hongda people firmly believe that without today's product quality, there will be no tomorrow's sales market, no today's customer satisfaction, no tomorrow's Hongda life. Hongda products always face the market with reasonable performance price, Hongda people hope to create Hongda brand with customers.

本文链接: https://brand.waitui.com/6e785b071.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

恒瑞医药:羟乙磺酸达尔西利片联合内分泌治疗乳腺癌III期临床试验达主要终点

36氪获悉,恒瑞医药公告称,公司自主研发的羟乙磺酸达尔西利片在激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性女性乳腺癌辅助治疗的III期临床试验中,首次期中分析主要终点达到统计学显著性。研究结果显示,达尔西利联合内分泌治疗可显著降低患者复发风险,提高患者无侵袭性疾病生存期(IDFS)。公司已向国家药品监督管理局药品审评中心递交上市前沟通交流申请。该药品是公司自主研发的化学药品1类新药,是一种口服、高效、选择性的小分子CDK4/6抑制剂。

2小时前

深圳:近期将发布人形机器人专项政策 在全市科技重大专项中安排人工智能和机器人专项

深圳市政府新闻办2月23日召开“打造最好科技创新生态和人才发展环境”主题新闻发布会。市人工智能产业办主任林毅在会上表示,深圳在人工智能和机器人领域基础雄厚、未来可期。下一步,我们将在政策、场景、创新、机器人四个方面持续发力。此外,近期我们还将发布人形机器人专项政策,通过“揭榜挂帅”等方式,对开放应用场景、突破关键技术、构建专用数据集、提升规模化制造和应用能力等予以精准支持。同时,还将在全市科技重大专项中安排人工智能和机器人专项,鼓励产、学、研、用组成创新联合体进行协同攻关。(财联社)

2小时前

一汽大众ID.系列部分车型官降至高5.5万元

一汽-大众宣布对旗下ID.系列部分车型进行降价,最高降幅达5.5万元。此次降价活动涉及ID.4 CROZZ和ID.6 CROZZ两款车型,无门槛一口价分别为13.99万元和19.59万元起,还可叠加官方置换补贴至高1万元、国家置换补贴至高2万元。(财联社)

2小时前

2025年中央一号文件发布

36氪获悉,2025年中央一号文件2月23日发布,《中共中央 国务院关于进一步深化农村改革 扎实推进乡村全面振兴的意见》提出,以改革开放和科技创新为动力,巩固和完善农村基本经营制度,深入学习运用“千万工程”经验,确保国家粮食安全,确保不发生规模性返贫致贫,提升乡村产业发展水平、乡村建设水平、乡村治理水平,千方百计推动农业增效益、农村增活力、农民增收入,为推进中国式现代化提供基础支撑,这是党的十八大以来第13个指导“三农”工作的中央一号文件。

2小时前

海天味业:公司发行H股备案申请材料获中国证监会接收

36氪获悉,海天味业公告称,公司已于2025年1月13日向香港联交所递交了发行H股股票并在香港联交所主板挂牌上市的申请。公司已向中国证监会报送了关于公司本次发行的备案申请材料并于近日获中国证监会接收。该事项仍存在不确定性,公司将根据进展情况及时履行信息披露义务。

2小时前

本页详细列出关于海氏海诺的品牌信息,含品牌所属公司介绍,海氏海诺所处行业的品牌地位及优势。
咨询